First-Time Adult Seizures May Signal Brain Tumor, Doctors Warn
Medical specialists are warning that first-time seizures in adults should be investigated promptly as they may indicate an underlying brain tumor. Late-onset seizures are among the most important early indicators of possible brain tumors, and even a single episode warrants neurological evaluation and imaging. Early diagnosis is critical because outcomes remain poor in aggressive brain tumors like gliomas, though advances in imaging and precision medicine are improving treatment options.
Following World Brain Tumour Day on June 8, medical specialists in India have emphasized that first-time seizures occurring in adulthood should never be ignored, as they could represent the earliest detectable sign of a brain tumor. According to doctors quoted from major hospitals, late-onset seizures warrant prompt investigation with imaging technology. Brain tumors account for a significant portion of central nervous system cancers according to India's National Cancer Registry Programme, with particularly poor outcomes in aggressive malignancies such as gliomas. Recent advances in diagnostic technology—including improved imaging quality, digitalization, and neuronavigation—have enhanced the precision of brain tumor diagnosis over the past decade. Treatment options now include surgery, radiation, and increasingly, targeted therapies based on comprehensive genome profiling and gene sequencing, reflecting the growing role of precision medicine in neuro-oncology.
What different sources said
- The HinduCenter
Seizures could be early indicator of brain tumour, caution doctors
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.